← Leaderboards
Sampath Parthasarathy
Emory University
$11,379,014
Attributed
$12,089,299
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$14,416,788 · 11
By mechanism
R01$11,154,530 · 7
P01$3,241,123 · 3
M01$21,135 · 1
Top collaborators
- Dinender Kumar Singla4 shared
Most similar at Emory University
Same institution · by research overlap
- David Marshall Guidot$16,778,978
- Raymond F. Schinazi$18,319,973
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisAntioxidantsOxidationAffectMacrophageBasePlayPreventAnimalsCellsHuman SubjectOxidative StressCholesterolFatty AcidsIn VitroAntiatherogenicInflammationMediatingGene ExpressionGenesPathologic ProcessDietary LipidNutrition Related TagAnti-Inflammatory Agents
Grant awards (44)
Role of aldehyde oxidation in atherosclerosis$362,928
R01 · FY2017 · HL · contact PI
BMP-7 induced Macrophage Polarization in Atherosclerosis$363,084
R01 · FY2016 · HL
Role of aldehyde oxidation in atherosclerosis$363,081
R01 · FY2016 · HL · contact PI
BMP-7 induced Macrophage Polarization in Atherosclerosis$357,777
R01 · FY2015 · HL
Role of aldehyde oxidation in atherosclerosis$357,774
R01 · FY2015 · HL · contact PI
Non-pharmacological control of atherosclerosis$366,115
R01 · FY2014 · AT · contact PI
Role of aldehyde oxidation in atherosclerosis$363,355
R01 · FY2014 · HL · contact PI
BMP-7 induced Macrophage Polarization in Atherosclerosis$356,090
R01 · FY2014 · HL
Non-pharmacological control of atherosclerosis$366,115
R01 · FY2013 · AT · contact PI
BMP-7 induced Macrophage Polarization in Atherosclerosis$343,619
R01 · FY2013 · HL
Non-pharmacological control of atherosclerosis$377,438
R01 · FY2012 · AT · contact PI
Novel mechanisms by which aspirin might protect against atherosclerosis$358,875
R01 · FY2012 · HL · contact PI
Novel mechanisms by which aspirin might protect against atherosclerosis$326,947
R01 · FY2011 · HL · contact PI
Non-pharmacological control of atherosclerosis$296,772
R01 · FY2011 · AT · contact PI
Non-pharmacological control of atherosclerosis$80,666
R01 · FY2011 · AT · contact PI
Novel mechanisms by which aspirin might protect against atherosclerosis$48,053
R01 · FY2011 · HL · contact PI
Non-pharmacological control of atherosclerosis$381,250
R01 · FY2010 · AT · contact PI
Novel mechanisms by which aspirin might protect against atherosclerosis$375,000
R01 · FY2010 · HL · contact PI
Novel mechanisms by which aspirin might protect against atherosclerosis$375,000
R01 · FY2009 · HL · contact PI
Novel mechanisms by which aspirin might protect against atherosclerosis$375,000
R01 · FY2008 · HL · contact PI
CLINICAL TRIAL: SESAME OIL CONSUMPTION ON CARDIOVASCULAR RISK FACTORS IN HEALTHY$21,135
M01 · FY2008 · RR · contact PI
Oxidation Hypothesis--Paradoxes and Pitfalls$346,656
R01 · FY2006 · HL · contact PI
Oxidation Hypothesis--Paradoxes and Pitfalls$355,000
R01 · FY2005 · HL
Oxidation Hypothesis--Paradoxes and Pitfalls$355,000
R01 · FY2004 · HL
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSIS$249,920
R01 · FY2004 · DK
Oxidation Hypothesis--Paradoxes and Pitfalls$380,000
R01 · FY2003 · HL
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSIS$267,520
R01 · FY2003 · DK
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSIS$267,520
R01 · FY2003 · DK
MACROPHAGES, OXIDATION, AND ENDOMETRIOSIS$802,592
P01 · FY2002 · HD
EXERCISE AND CARDIOVASCULAR DISEASE$380,000
R01 · FY2002 · HL
Oxidation Hypothesis--Paradoxes and Pitfalls$370,640
R01 · FY2002 · HL
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSIS$267,520
R01 · FY2002 · DK
ACTIVE ROLE FOR THE PERITONEAL FLUID IN THE DEVELOPMENT OF ENDOMETRIOSIS$165,355
P01 · FY2002 · HD
MACROPHAGE ENDOMETRIAL CELL INTERACTIONS IN ENDOMETRIOSIS$165,355
P01 · FY2002 · HD
MACROPHAGES, OXIDATION, AND ENDOMETRIOSIS$783,721
P01 · FY2001 · HD
EXERCISE AND CARDIOVASCULAR DISEASE$381,042
R01 · FY2001 · HL
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSIS$269,280
R01 · FY2001 · DK
ACTIVE ROLE FOR THE PERITONEAL FLUID IN THE DEVELOPMENT OF ENDOMETRIOSIS$165,355
P01 · FY2001 · HD
MACROPHAGE ENDOMETRIAL CELL INTERACTIONS IN ENDOMETRIOSIS$165,355
P01 · FY2001 · HD
MACROPHAGES, OXIDATION, AND ENDOMETRIOSIS$741,176
P01 · FY2000 · HD
EXERCISE AND CARDIOVASCULAR DISEASE$374,508
R01 · FY2000 · HL
DIETARY OXIDIZED LIPIDS AND ATHEROSCLEROSIS$294,985
R01 · FY2000 · DK
ACTIVE ROLE FOR THE PERITONEAL FLUID IN THE DEVELOPMENT OF ENDOMETRIOSIS$126,107
P01 · FY2000 · HD
MACROPHAGE ENDOMETRIAL CELL INTERACTIONS IN ENDOMETRIOSIS$126,107
P01 · FY2000 · HD